[Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].

@article{Yang2008PosttransplantPO,
  title={[Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].},
  author={Yang Yang and Jian Zhang and Hui-min Yi and Min-qiang Lu and Chang-Jie Cai and Xi Li and Nan Jiang and Chi Xu and Hua Li and Gen-shu Wang and Shu-hong Yi and Jun-feng Zhang and Hua Jiang and Qing Yang and Guihua Chen},
  journal={Nan fang yi ke da xue xue bao = Journal of Southern Medical University},
  year={2008},
  volume={28 10},
  pages={1810-2}
}
OBJECTIVE To evaluate the prophylactic efficacy of adefovir dipivoxil (ADV) for post-transplant recurrence of hepatitis B virus (HBV) with lamivudine-resistant YMDD mutation in liver recipients. METHODS From March 2004 to May 2006, 20 patients with chronic hepatitis B associated with YMDD mutant HBV prior to liver transplantation received treatment with… CONTINUE READING